Valuation : Divi's Laboratories Limited

Market Cap 2,453B 25.66B 22.11B 20.73B 18.93B 35.65B 35.77B 246B 95.98B 1,238B 96.35B 94.25B 4,105B P/E 2027 *
75.2x
P/E 2028 * 62.4x
Enterprise Value 2,418B 25.3B 21.8B 20.44B 18.66B 35.15B 35.26B 242B 94.61B 1,220B 94.97B 92.91B 4,047B EV / Sales 2027 *
19.2x
EV / Sales 2028 * 16.1x
Free-Float
48.01%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day+1.98%
1 week+7.47%
Current month+14.68%
1 month+18.68%
3 months+38.58%
6 months+44.17%
Current year+44.53%
1 week 8,457.5
Extreme 8457.5
9,270
1 month 7,870.5
Extreme 7870.5
9,270
Current year 5,647.5
Extreme 5647.5
9,270
1 year 5,636.5
Extreme 5636.5
9,270
3 years 3,295.3
Extreme 3295.3
9,270
5 years 2,730
Extreme 2730
9,270
10 years 532.65
Extreme 532.65
9,270
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%+7.47%+50.68%+152.63% 25.66B
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.48%-1.66%+30.70%+58.42% 368.49B
Weighted average by Cap. -0.45%-3.38%+38.26%+65.61%

Financials

2027 *2028 *
Net sales 126B 1.32B 1.13B 1.06B 970M 1.83B 1.83B 12.61B 4.92B 63.48B 4.94B 4.83B 210B 150B 1.57B 1.35B 1.27B 1.16B 2.18B 2.19B 15.03B 5.87B 75.67B 5.89B 5.76B 251B
Net income 32.65B 342M 294M 276M 252M 475M 476M 3.27B 1.28B 16.48B 1.28B 1.25B 54.65B 39.42B 412M 355M 333M 304M 573M 575M 3.95B 1.54B 19.9B 1.55B 1.51B 65.98B
Net Debt -35B -366M -316M -296M -270M -509M -510M -3.51B -1.37B -17.67B -1.37B -1.34B -58.58B -44.85B -469M -404M -379M -346M -652M -654M -4.5B -1.76B -22.64B -1.76B -1.72B -75.08B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
28/08/26 INR 9,239.00 +1.98% 773,225
27/08/26 INR 9,060.00 +0.39% 527,307
26/08/26 INR 9,025.00 +3.21% 708,128
25/08/26 INR 8,744.50 +2.92% 563,721
24/08/26 INR 8,496.00 -1.17% 251,013
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,239.00INR
Average target price
8,447.00INR
Spread / Average Target
-8.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock